2019 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2013 | |
Criterium: | Position: |
Overall Score: | 600-700 |
Total Project Funding per Partner: | 300-400 |
Total Number of Projects: | 69 |
Total Project Funding: | 300-400 |
Partner Constancy: | 58 |
Project Leadership Index: | 69 |
Diversity Index: | 64 |
2009 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2019 | 0 | 3.664.174 | 0 | 1 | ||
2013 | 0 | 41.108.321 | 3.075.173 | 5 |
Total number of partners: 79
Partner loyalty:
Frequent Partner: (> 2 projects): 3
Rare Partner: 76
Frequent / Rare Partner Ratio: 0.04
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2019-05-01 | ENdoThelial macRophage Alliance In Neuroinflammation | ENTRAIN | participant | 3.664.174 | 20 |
2013-12-01 | Vaccination In Atherosclerosis | VIA | participant | 5.994.233 | 12 |
2013-11-01 | Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer | CAM-PAC | participant | 11.193.108 | 14 |
2013-10-01 | Identification and validation of novel pharmaceutical drug targets for cardiovascular disease | CARTARDIS | participant | 5.973.521 | 13 |
2013-10-01 | Systems biology for the functional validation of genetic determinants of skeletal diseases | SYBIL | participant | 11.968.569 | 18 |
2013-09-01 | Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers | TUMADOR | participant | 5.978.890 | 8 |